The expression of C/EBPβ-LAP1 variant, but not LAP2 and LIP, is significantly downregulated in hepatocellular carcinoma, squamous cell carcinoma, breast cancer and elevated LIP:LAP ratio is observed in high proliferative tumors [132,133,134]. The gene discussed is TGFB1; the disease is breast carcinoma.